文献速递冠心病外科

冠状动脉旁路移植术后围术期心肌梗死的临床实践与未来展望

Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

欧洲心胸外科协会支持的国际调查评估了CABG后围术期心肌梗死(PMI)的定义、生物标志物及诊断准确性要求。175名来自29个国家的受访者完成问卷。结果显示PMI定义使用差异大,UDMI-4最常用,并提出了未来定义所需的生物标志物浓度和敏感度/特异度阈值。

要点

  • PMI定义使用差异大,UDMI-4最常用(67.4%)。
  • 提出了有/无影像学证据时定义PMI的生物标志物浓度。
  • 未来定义最低可接受敏感度95%,特异度90%,敏感度更重要。

核心结论

  • PMI定义使用广泛变异,UDMI-4最常用,亟需标准化的CABG特异性PMI定义。

主要发现

  • 46.4%的受访者使用特定PMI定义,其中UDMI-4占67.4%,SCAI占16.3%,ARC-2占6.1%,其他占10.2%。
  • 受访者认为定义PMI的生物标志物浓度(有影像学证据支持时):hs-cTnT 489 ng/L,hs-cTnI 425 ng/L,CKMB-mass 90 μg/L,CKMB-activity 100 U/L。
  • 无影像学证据支持时:hs-cTnT 931 ng/L,hs-cTnI 1458 ng/L,CKMB-mass 100 μg/L,CKMB-activity 300 U/L。
  • 未来定义的最低可接受敏感度和特异度阈值分别为95% [90%-95%]和90% [80%-95%],敏感度被认为比特异度更重要(79.8% vs 20.2%,P < .001)。

关键数值与推荐

  • 有影像学证据时PMI生物标志物阈值:hs-cTnT 489 ng/L,hs-cTnI 425 ng/L,CKMB-mass 90 μg/L,CKMB-activity 100 U/L。
  • 无影像学证据时PMI生物标志物阈值:hs-cTnT 931 ng/L,hs-cTnI 1458 ng/L,CKMB-mass 100 μg/L,CKMB-activity 300 U/L。
  • 未来定义最低可接受敏感度95% [90%-95%],特异度90% [80%-95%]。

临床怎么用

  • 临床中应关注PMI定义的标准化,目前UDMI-4使用最广,但需结合CABG特异性标准。
  • 生物标志物阈值和诊断准确性要求可为未来定义提供参考。

局限性

  • 调查基于受访者观点,可能不代表所有临床实践。
  • 样本量175名,来自29个国家,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The definitions of periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG) are heavily debated. A European Association for Cardiothoracic Surgery (EACTS)-endorsed international survey was conducted to evaluate current clinical practices and to reach a consensus-based agreement on the diagnostic characteristics required for a potential future PMI definition. METHODS: The questionnaire complied with the CHERRIES guideline. A pilot version underwent iterative testing. The final version was distributed to all members of EACTS and allied specialties. The questionnaire evaluated definitions, biomarkers, and required diagnostic accuracy and was distributed between August-November 2024. RESULTS: The questionnaire was completed by 175 respondents (surgeons: 71.4%, cardiologists: 20.6%, intensivists: 5.1%, other: 2.9%) from 29 countries. A specific definition of PMI was used by 46.4% of respondents (Universal Definition of Myocardial Infarction [UDMI]-4: 67.4%, Society of Cardiovascular Angiography and Interventions [SCAI]: 16.3%, second Academic Research Consortium [ARC-2]: 6.1%, other: 10.2%). Respondents identified biomarker concentrations defining PMI with supporting (imaging) evidence (high-sensitivity cardiac troponin T [hs-cTnT]: 489 ng/L, high-sensitivity cardiac troponin I [hs-cTnI]: 425 ng/L, CKMB-mass: 90ug/L, CKMB-activity: 100 U/L) and without (hs-cTnT: 931 ng/L, hs-cTnI: 1458 ng/L, CKMB-mass: 100ug/L, CKMB-activity: 300UL). The lowest acceptable sensitivity and specificity thresholds for a future definition were 95% [90%-95%] and 90% [80%-95%], respectively, while sensitivity was deemed more important than specificity (79.8% vs 20.2%, P < .001). CONCLUSIONS: The use of PMI definitions varies widely, though UDMI-4 is most frequently employed. Our findings highlight the need for a standardized, CABG-specific PMI definition with robust diagnostic accuracy to enable consistent diagnoses and a common clinical language.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Swinnen B, Olsthoorn JR, Mihl C, et al. Periprocedural Myocardial Infarction After Coronary Artery Bypass Grafting: Current Clinical Practices and Future Perspectives. Eur J Cardiothorac Surg. 2025. PMID: 41063612. doi:10.1093/ejcts/ezaf344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。